-
Product Insights
NewMast/Stem Cell Growth Factor Receptor Kit – Drugs In Development, 2024
The Mast/Stem Cell Growth Factor Receptor Kit pipeline drugs market research report outlays comprehensive information on the Mast/Stem Cell Growth Factor Receptor Kit targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Gastrointestinal, and Dermatology which include indications of Gastrointestinal Stromal Tumor (GIST), Solid Tumor, Inflammation, Anaphylaxis, Systemic Mastocytosis, Eosinophilic Esophagitis, Chronic Urticaria Or Hives, and...
-
Company Insights
NewJBS Science Inc Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our JBS Science Inc Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. JBS Science Inc is engaged in the development and application of circulating cell-free DNA (cfDNA) technology to enhance cancer screening. The company's products includes nucleic acid purification, spike-in DNA control kit, DNA pure clean-up kit, PCR kits, droplet digital PCR kits, urine collection kits, and NGS-related products. The company is headquartered in Doylestown, Pennsylvania, the US. GlobalData's Medical Devices...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Briquilimab in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Briquilimab in Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Briquilimab in Acute Myelocytic Leukemia (AML,...
-
Sector Analysis
NewDental Materials Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Dental Materials Market Report Overview The dental materials market size was valued at $736.6 million in 2023. Factors such as increasing incidence of dental diseases and ailments and growing elderly populations will drive the market at a CAGR of more than 5% during the forecast period. Dental Materials Market Outlook, 2023-2033 ($ Million) Buy the Full Report for More Insights into the Dental Materials Market Forecast, Download a Free Report Sample The dental materials market research report explains the market...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Avapritinib in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Avapritinib in Refractory Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Avapritinib in Refractory Acute Myeloid Leukemia Drug Details: Avapritinib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Avapritinib in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Avapritinib in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Avapritinib in Relapsed Acute Myeloid Leukemia Drug Details: Avapritinib...
-
Product Insights
NewMiRXES Pte Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our MiRXES Pte Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. MiRXES Pte Ltd (MiRXES) is a molecular diagnostic company specialized in microRNA technologies developing diagnostic test kits and clinical services for early detection of cancer and infectious diseases. It offers GASTROClear, a liquid biopsy test kit for early detection of gastric cancer; Fortitude kit for testing COVID-19; swab collection kits to collect and store viral-infected throat or nasal swabs...
-
Product Insights
NewTBG Diagnostics Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our TBG Diagnostics Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and services. The company’s major products include COVID 19 testing kits, nucleic acid extraction kits, HLA SBT typing kits, HPA genotyping kits, automated pipetting system, and gel electrophoresis. It serves clinical laboratories of hospitals and independent...
-
Company Insights
NewMaxim Biomedical Inc Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Maxim Biomedical Inc Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Maxim Biomedical Inc (Maxim Biomedical) is a medical diagnostic company that offers diagnostic kits. It provides screening and supplemental tests for human immunodeficiency virus type 1 antibodies. The company's products include enzyme immunoassay, western bolt kits, enzyme immunoassay, lateral flow immunoassay, buffers, equipment and others. Maxim Biomedical also provides western blot auto process instruments; manual and auto chemiluminescence immunoassay...